Tiziana Life Sciences (TLSA) Stock Statistics & Valuation Metrics
Total Valuation
Tiziana Life Sciences has a market cap or net worth of $102.65M. The enterprise value is -$65.27T.
- Market Cap
- $102.65M
- Enterprise Value
- -$65.27T
Share Statistics
Tiziana Life Sciences has 128,309,130 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 128,309,130
- Owned by Insiders
- 74.65%
- Owned by Institutions
- 0.55%
Financial Efficiency
Tiziana Life Sciences’s return on equity (ROE) is -354.44 and return on invested capital (ROIC) is -4159.84%.
- Return on Equity (ROE)
- -354.44
- Return on Assets (ROA)
- -1.60
- Return on Invested Capital (ROIC)
- -4159.84%
- Return on Capital Employed (ROCE)
- -73.89
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.84M
- Employee Count
- 10
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Tiziana Life Sciences is -3.36. Tiziana Life Sciences’s PEG ratio is 0.05.
- PE Ratio
- -3.36
- PS Ratio
- 0.00
- PB Ratio
- -32.12
- Price to FCF
- -6.53
- Price to Operating Cash Flow
- -6.60
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, Tiziana Life Sciences had revenue of 0 and earned -18.43M in profits. Earnings per share was -0.16.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -21.13M
- Pretax Income
- -18.43M
- Net Income
- -18.43M
- EBITDA
- -18.18M
- Earnings Per Share (EPS)
- -0.16
Cash Flow
In the last 12 months, operating cash flow was -13.38M and capital expenditures -75,000, giving a free cash flow of -13.46M billion.
- Operating Cash Flow
- -13.38M
- Free Cash Flow
- -13.46M
- Free Cash Flow per Share
- -0.11
Dividends & Yields
Tiziana Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -15.32%
- Earnings Yield
- -28.54%
Stock Price Statistics
- Beta
- -0.16
- 52-Week Price Change
- -62.90%
- 50-Day Moving Average
- 1.00
- 200-Day Moving Average
- 1.21
- Relative Strength Index (RSI)
- 29.35
- Average Volume (3m)
- 785.53K
Financial Position
Tiziana Life Sciences as a current ratio of 0.76, with Debt / Equity ratio of 876.92%
- Current Ratio
- 0.76
- Quick Ratio
- 0.76
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.20
- Interest Coverage Ratio
- -1174.00
Taxes
In the past 12 months, Tiziana Life Sciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Tiziana Life Sciences EV to EBITDA ratio is -3.44, with an EV/FCF ratio of -6.36.
- EV to Sales
- 0.00
- EV to EBITDA
- -3.44
- EV to Free Cash Flow
- -6.36
- EV to Operating Cash Flow
- -6.40
Balance Sheet
Tiziana Life Sciences has $3.18M in cash and marketable securities with $932.00K in debt, giving a net cash position of $2.25M billion.
- Cash & Marketable Securities
- $3.18M
- Total Debt
- $932.00K
- Net Cash
- $2.25M
- Net Cash Per Share
- $0.02
- Tangible Book Value Per Share
- -$0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Tiziana Life Sciences is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $7.00
- Price Target Upside
- 914.49% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -78.92%
Scores
- Smart Score
- 9
- AI Score
- ―
